Factors Affecting Seroconversion Rates in Cattle Vaccinated with Two Commercial Inactivated BTV-8 Vaccines Under Field Conditions.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Transboundary and Emerging Diseases

• Publication date

  2016-04-01

• Fields of study

  Agricultural and Food Sciences, Medicine

• Identifiers
  DOI 10.1111/tbed.12241PMID 24903759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term persistence of neutralising antibodies against bluetongue virus serotype 8 in naturally infected cattle.

  2012cited by this paper
• Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine.

  2012cited by this paper
• Novel Bluetongue Virus Serotype from Kuwait

  2011cited by this paper
• The presence of bluetongue virus serotype 8 RNA in Belgian cattle since 2008.

  2011cited by this paper
• Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.

  2010cited by this paper
• Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.

  2009cited by this paper
• Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observations in field and experimental infection of goats and sheep.

  2009cited by this paper
• Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

  2009cited by this paper
• Epidemiology of Bluetongue Virus Serotype 8, Germany

  2009cited by this paper
• Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.

  2009cited by this paper
• Bluetongue virus: virology, pathogenesis and immunity.

  2008cited by this paper
• Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands.

  2008cited by this paper
• Vaccines against bluetongue in Europe.

  2008cited by this paper
• Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.

  2008cited by this paper
• Opinion of the Scientific Panel on Animal Health and Welfare on request from the Commission on bluetongue.

  2008cited by this paper
• Bluetongue virus isolations from midges belonging to the Obsoletus complex (Culicoides, Diptera: Ceratopogonidae) in Italy

  2005cited by this paper
• Bluetongue in Italy: Part I.

  2004cited by this paper
• Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.

  2004cited by this paper
• Bluetongue virus in the Mediterranean Basin 1998-2001.

  2002cited by this paper

• BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.

  2019cites this paper
• Estimation of French cattle herd immunity against bluetongue serotype 8 at the time of its re-emergence in 2015

  2018cites this paper